当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Trimix 40/30/4
HUMAN COMPOUNDED DRUG
26436-5275
Hybrid Pharma
2021/2/1 0:00:00
PAPAVERINE HYDROCHLORIDE; ALPROSTADIL; PHENTOLAMINE MESYLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 mg/1 mL; 30 ug/1 mL; 4 mg/1 mL
26436-5275-1
Trimix 10/7.5/0.2
HUMAN COMPOUNDED DRUG
26436-5555
Hybrid Pharma
2021/2/1 0:00:00
ALPROSTADIL; PAPAVERINE HYDROBROMIDE; PHENTOLAMINE MESYLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL; 7.5 mg/1 mL; .2 mg/1 mL
26436-5555-1
Hydromorphone HCl
HUMAN COMPOUNDED DRUG
71266-9110
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
71266-9110-4
Hydromorphone HCl
HUMAN COMPOUNDED DRUG
71266-9110
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
71266-9110-3
Ketamine
HUMAN COMPOUNDED DRUG
71266-9070
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL
71266-9070-2
Rocuronium Bromide
HUMAN COMPOUNDED DRUG
71266-2002
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
ROCURONIUM BROMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71266-2002-1
Glycopyrrolate
HUMAN COMPOUNDED DRUG
71266-2004
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
GLYCOPYRROLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
71266-2004-2
Glycopyrrolate
HUMAN COMPOUNDED DRUG
71266-2004
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
GLYCOPYRROLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
71266-2004-1
B Complex
HUMAN COMPOUNDED DRUG
72833-726
ASP Cares
2021/2/1 0:00:00
THIAMINE HYDROCHLORIDE; BENZYL ALCOHOL; RIBOFLAVIN 5'-PHOSPHATE SODIUM; NIACINAMIDE; DEXPANTHENOL; PYRIDOXINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/1 mL; 20 mg/1 mL; 2 mg/1 mL; 100 mg/1 mL; 2 mg/1 mL; 2 mg/1 mL
72833-726-30
Calcium Gluconate
HUMAN COMPOUNDED DRUG
72833-944
ASP Cares
2021/2/1 0:00:00
CALCIUM GLUCONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL
72833-944-12
Calcium Gluconate
HUMAN COMPOUNDED DRUG
72833-738
ASP Cares
2021/2/1 0:00:00
CALCIUM GLUCONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
72833-738-12
L-Arginine
HUMAN COMPOUNDED DRUG
72833-787
ASP Cares
2021/2/1 0:00:00
ARGININE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg/1 mL
72833-787-04
Biotin
HUMAN COMPOUNDED DRUG
72833-589
ASP Cares
2021/2/1 0:00:00
BIOTIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
72833-589-30
Naloxone Hydrochloride
HUMAN COMPOUNDED DRUG
72833-686
ASP Cares
2021/2/1 0:00:00
NALOXONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
72833-686-02
Dexamethasone Phosphate
HUMAN COMPOUNDED DRUG
72833-488
ASP Cares
2021/2/1 0:00:00
DEXAMETHASONE SODIUM PHOSPHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
24 mg/1 mL
72833-488-01
BLT 20/8/4 DMSO
HUMAN COMPOUNDED DRUG
26436-5433
Hybrid Pharma
2021/2/1 0:00:00
BENZOCAINE; TETRACAINE; LIDOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 g; 40 mg/1 g; 80 mg/1 g
26436-5433-1
DICLOFENAC SODIUM DMSO 16/10
HUMAN COMPOUNDED DRUG
26436-5578
Hybrid Pharma
2021/2/1 0:00:00
DICLOFENAC SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
160 mg/1 g
26436-5578-1
Buprenorphine 0.4mg/mL PF
HUMAN COMPOUNDED DRUG
26436-5500
Hybrid Pharma
2021/2/1 0:00:00
BUPRENORPHINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.4 mg/1 mL
26436-5500-3
Trimix 20/30/2
HUMAN COMPOUNDED DRUG
26436-5176
Hybrid Pharma
2021/2/1 0:00:00
PAPAVERINE HYDROCHLORIDE; ALPROSTADIL; PHENTOLAMINE MESYLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 mg/1 mL; 25 ug/1 mL; 2 mg/1 mL
26436-5176-2
BLT 20/8/8
HUMAN COMPOUNDED DRUG
26436-5382
Hybrid Pharma
2021/2/1 0:00:00
BENZOCAINE; TETRACAINE; LIDOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 g; 80 mg/1 g; 80 mg/1 g
26436-5382-1
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3